Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	68.13B
Revenue (ttm)	40.54B
Net Income (ttm)	2.23B
Shares Out	32.69M
EPS (ttm)	64.27
PE Ratio	32.43
Forward PE	18.86
Dividend	58.00 (2.80%)
Ex-Dividend Date	Sep 29, 2025

Volume	115,100
Average Volume	121,720
Open	2,100.00
Previous Close	2,084.00
Day's Range	2,071.00 - 2,112.00
52-Week Range	1,849.00 - 2,568.00
Beta	0.18
RSI	46.97
Earnings Date	Jul 25, 2025

About Eiken Chemical

Eiken Chemical Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 702
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In 2024, Eiken Chemical's revenue was 40.54 billion, an increase of 1.22% compared to the previous year's 40.05 billion. Earnings were 2.23 billion, a decrease of -15.41%.